NASDAQ:ZLAB Stock Quote
37.29
+1.11 (3.07%)
Zai Lab Ltd is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for the treatment of cancer and autoimmune diseases
With a strong emphasis on research and development, Zai Lab aims to address unmet medical needs through its diverse portfolio of drug candidates, which includes both in-house programs and strategic collaborations with other biopharmaceutical companies. The company's commitment to advancing healthcare solutions is reflected in its efforts to bring novel treatments to market, thereby improving the quality of life for patients globally.
Via Benzinga · March 28, 2025
Via Benzinga · March 27, 2025

NovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges.
Via The Motley Fool · February 27, 2025

Via Benzinga · February 18, 2025

Zai Lab shares are trading higher by 4% during Friday's session. The company priced a $200 million public offering.
Via Benzinga · November 15, 2024

Via The Motley Fool · December 5, 2024

NovoCure and Zai Lab report PANOVA-3 trial success with TTFields therapy, achieving significant survival benefits for pancreatic cancer patients.
Via Benzinga · December 2, 2024

Via Benzinga · November 15, 2024

The company is working on an antibody drug conjugate, which is like a smart bomb for cancer cells.
Via Investor's Business Daily · October 24, 2024

Via Benzinga · October 24, 2024

Via Benzinga · September 25, 2024

Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024.
Via InvestorPlace · July 26, 2024

DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance.
Via InvestorPlace · July 26, 2024

A compelling hidden-gem opportunity, Zai Lab’s groundbreaking cancer therapeutic and discounted valuation could drive up ZLAB stock.
Via InvestorPlace · July 26, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

Via Benzinga · May 9, 2024

Via Benzinga · May 9, 2024

Via Benzinga · May 9, 2024

Via Benzinga · May 9, 2024

Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
Via InvestorPlace · May 9, 2024

ZLAB stock results show that Zai Lab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024